Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

Scimed division's radiofrequency-based percutaneous transmyocardial revascularization (PTMR) ablation catheter offers a highly effective, low-cost alternative to laser-based PTMR devices, Robert Schwartz, Mayo Clinic and Foundation, says March 10 at the ACC conference. Results from ongoing animal studies show that Scimed's 500 kilohertz RF ablation catheter is "eminently controllable" and "very low cost...using a driver box readily available in most surgical labs," Schwartz said. The procedure has "a very high success rate because of its controllability and because of the fact that one does not need fibers as in the laser based context, but simply an electrode in a catheter," he explains
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011452

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel